Fed. Circ. Axes Teva MS Drug Patent In High Court Remand
The Federal Circuit found again Thursday that a patent on Teva Pharmaceutical Industries Ltd.'s multiple sclerosis drug Copaxone is invalid as indefinite, even though the U.S. Supreme Court ordered it to...To view the full article, register now.
Already a subscriber? Click here to view full article